Photograph of equipemnt at the beamline BioMAX

BioMAX is one of two X-ray macromolecular crystallography beamlines at MAX IV Laboratory. It has been in user operation since 2017. Designed for stability, reliability, and ease of use, BioMAX offers a streamlined experimental setup with fully or highly automated data collection capabilities.

The beamline supports a wide range of experimental techniques, including experimental phasing, in situ screening, and fixed-target synchrotron-based serial crystallography (SSX). Remote data collection is available by default, ensuring flexible access for researchers worldwide. Additionally, BioMAX is home to FragMAX, MAX IV’s dedicated platform for fragment-based drug discovery.

Available forTechnique description
General UsersConventional rotation data collection (fixed point or helical) at a wide range of energies and variable beam size.
General UsersAutomated sample mounting and dismounting from UniPucks, 29 puck positions in dewar.
General UsersSample temperature 100 K; room temperature with or without humidity control available for manual mounting only.
General UsersSAD and MAD experiments. Interleaved data collection.
General UsersAutomated data integration, scaling and merging. Offline remote access for manual data processsing.
General UsersSX experiments using fixed target or flow chips compatible with the MD3 minikappa. Please contact beamline manager.
General UsersElement identification by X-ray Fluorescence. Fast energy scans.
General UsersAutomated data collection.
General UsersRemote data collection.
General UsersIn-situ screening with different plate types. Please contact beamline manager.
General UsersFragment-based drug screening. Please contact beamline manager.
Commissioning UsersAutomated sample mounting and dismounting of samples in capillaries. Please contact beamline manager.
See also BioMAX User Information.

Beamline documents

Macromolecular Crystallography Review Report (download PDF)

https://www.youtube.com/watch?v=0LGCJx49OqE

Page manager: Ana Gonzalez June 30, 2025